Genistein inhibits prostate cancer cell growth by targeting miR-34a and oncogenic HOTAIR.

Por Takeshi Chiyomaru, Soichiro Yamamura, Shinichiro Fukuhara, Hirofumi Yoshino, Takashi Kinoshita, Shahana Majid, Sharanjot Saini, Inik Chang, Yuichiro Tanaka, Hideki Enokida, Naohiko Seki, Masayuki Nakagawa, Rajvir Dahiya
Publicado em 2013-01-01

Effects of immune checkpoint inhibitor therapy resumption in patients with malignant tumors after moderate-to-severe immune-related adverse events.

Por Machiko Kawahira, Shuji Kanmura, Keiko Mizuno, Kentaro Machida, Takao Ohtsuka, Masami Sato, Hideki Enokida, Masaru Yamashita, Takuro Kanekura, Shiho Arima, Norifumi Nakamura, Tsuyoshi Sugiura, Koji Yoshimoto, Hiroaki Kobayashi, Kenji Ishitsuka, Shinsuke Suzuki, Shinichi Ueno, Akio Ido
Publicado em 2022-01-01

Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled Trial

Por Kouji Izumi, Takashi Shima, Koji Mita, Yuki Kato, Manabu Kamiyama, Shogo Inoue, Nobumichi Tanaka, Seiji Hoshi, Takehiko Okamura, Yuko Yoshio, Hideki Enokida, Ippei Chikazawa, Noriyasu Kawai, Kohei Hashimoto, Takashi Fukagai, Kazuyoshi Shigehara, Shizuko Takahara, Yoshifumi Kadono, Atsushi Mizokami
Publicado em 2022-07-01